로딩 중…
지수 로딩 중…
Arcturus Therapeutics Holdings Inc.
ARCT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.53+2.31%
2026-06-18
Price Chart
Arcturus Therapeutics Holdings Inc.-39.03%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $214M |
| Revenue | $45M |
| Net Income | $-79M |
| Total Assets | $245M |
| Net Assets | $191M |
| Value | |
| P/B | 1.12x |
| P/S | 4.72x |
| FCF Yield | -27.52% |
| Profitability | |
| ROE | -41.11% |
| ROA | -32.06% |
| Op. Margin | -196.72% |
| Revenue Growth | -97.92% |
| Financial Health | |
| Debt Ratio | 28.24% |
| Total Debt | $20M |
| FCF | $-59M |
| Cash | $211M |
| Current Ratio | 6.31x |
| Performance | |
| 1Y Return | -39.03% |
| 1M Return | 12.56% |
| From 52W High | -68.85% |
| 1Y MDD | -74.53% |
| Trading | |
| Volume | 458,090 shares |
| Trading Value | $3M |
| Per Share | |
| EPS | $-2.40 |
| BPS | $7.81 |